People in the top 5% of this polygenic risk score distribution do have a 3-fold higher risk of CAD compared to the remainder of the population, but this is much less than the 15-fold relative risk of CAD among FH mutation carriers up to age 50. This evidence concerns the gene FH and coronary artery disorder.